Effect of plagiochin E, an antifungal macrocyclic bis(bibenzyl), on cell wall chitin synthesis in Candida albicans

Acta Pharmacologica Sinica

Volumn 29, Issue 12, 2008, Pages 1478-1485

  Wu, Xiu Zhen ^a   Cheng, Ai Xia ^a   Sun, Ling Mei ^a   Lou, Hong Xiang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Candida albicans; Cell wall; Chitin synthesis; Macrocyclic bis(bibenzyl); Plagiochin E

Indexed keywords

ANTIFUNGAL AGENT; CHITIN; CHITIN SYNTHASE; N ACETYLGLUCOSAMINE; PLAGIOCHIN E; UNCLASSIFIED DRUG; BIBENZYL DERIVATIVE; BRIDGED COMPOUND; FUNGAL PROTEIN; STILBENE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CELL LEVEL; CELL REGENERATION; CELL STRUCTURE; CELL ULTRASTRUCTURE; CELL WALL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG STRUCTURE; ELECTRON MICROSCOPY; ENZYMATIC ASSAY; GENE EXPRESSION; GENE SYNTHESIS; GENETIC TRANSCRIPTION; IN VITRO STUDY; INHIBITION KINETICS; MARCHANTIA; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPHEROPLAST; UPREGULATION; ANIMAL; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; ULTRASTRUCTURE;

ANIMALS; ANTIFUNGAL AGENTS; BIBENZYLS; BRIDGED COMPOUNDS; CANDIDA ALBICANS; CELL WALL; CHITIN; CHITIN SYNTHASE; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; HUMANS; MOLECULAR STRUCTURE; STILBENES;

EID: 64549090087     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2008.00900.x     Document Type: Article

References (51)

1. Fridkin SK, Jarvis WR. Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996; 9: 499-511.
2. Maschmeyer G. The changing epidemiology of invasive fungal infections: new threats. Int J Antimicrob Agents 2006; 27: 3-6.
3. Mcneil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001; 33: 641-7.
4. Urbina JM, Cortes JGG, Palma A, Lopez SN, Zacchino SA, Enriz RD, et al. Inhibitors of the fungal cell wall. Synthesis of 4-aryl-4- Narylamine-1-butenes and related compounds with inhibitory activities on β (1-3) glucan and chitin synthases. Bioorg Med Chem 2000; 8: 691-8.
5. Hitchcock CA. Resistance of Candida albicans to azole antifungal agents. Biochem Soc Trans 1993; 21: 1039-47.
6. Parkinson T, Falconer DJ, Hitchcock CA. Fluconazole resistance due to energy-dependent drug efflux in Candida glabrata. Antimicrob Agents Chemother 1995; 39: 1696-99.
7. Prasad R, Wergifosse P, Goffeau A, Balzi E. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genetic 1995; 27: 320-9.
8. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382-402.
9. Bardon A, Kamiya N, Toyota M, Takaoka S, Asakawa Y. Sesquiterpenoids, hopanoids and bis(bibenzyls) from the argentine liverwort Plagiochasma rupestre. Phytochem 1999; 52: 1323-9.
10. Hashimoto T, Irita H, Takaoka S, Tanaka M, Asakawa Y. New chlorinated cyclic bis(bibenzyls) from the liverworts Herbertus sakuraii and Mastigophora diclados. Tetrahedron 2000; 56: 3153-9.
11. Hashimoto T, Kanayama S, Fukuyama Y, Takaoka S, Tori M, Asakawa Y. Two novel macrocyclic bis(bibenzyls), isoplagiochins A and B from the liverwort Plagiochila fruticosa. Tetrahedron Lett 1994; 35: 911-2.
12. Asakawa Y, Toyota M, Tori M, Hashimoto T. Chemical structures of macrocyclic bis(bibenzyls) isolated from liverworts (Hepaticae). Spectroscopy 2000; 14: 149-75.
13. Qu JB, Xie CF, Guo HF, Yu WT, Lou HX. Antifungal dibenzofuran bis(bibenzyl)s from the liverwort Asterella angusta. Phytochem 2007; 68: 1767-74.
14. Keseru GM, Nógrádi M. The biological activity of cyclic bis(bibenzyls): a rational approach. Bioorg Med Chem 1995; 3: 1511-7.
15. Niu C, Qu JB, Lou HX. Antifungal bis[bibenzyls] from the Chinese liverwort Marchantia polymorpha L. Chem Biodivers 2006; 3: 34-40.
16. Leng P, Guo XL, Yang Y, Lou HX. Primary study on antifungal activities and reversal of fluconazole resistance of PLE. Chin Pharm J 2007; 42: 349-52.
17. Carrillo-Muñoz AJ, Giusiano G, Ezkurra PA, Quindós G. Antifungal agents: mode of action in yeast cells. Rev Esp Quimioterap 2006; 19: 130-9.
18. Ghannoum MA, Rice LB. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 1999; 12: 501-17.
19. Bowman SM, Free SJ. The structure and synthesis of the fungal cell wall. BioEssays 2006; 28: 799-808.
20. Latgé JP. The cell wall: a carbohydrate armour for the fungal cell. Mol Microbiol 2007; 66: 279-90.
21. Georgopapadakou NH, Tkacz JS. The fungal cell wall as a drug target. Trends Microbiol 1995; 3: 98-104.
22. Perfect JR. Molecular targets for new antifungal drugs. Can J Bot 1995; 73 Suppl 1: 1187-91.
23. Lipke PN, Ovalle R. Cell wall architecture in yeast: new structure and new challenges. JBacteriol 1998; 180: 3735-40.
24. Osumi M. The ultrastructure of yeast: cell wall structure and formation. Micron 1998; 29: 207-33.
25. Mio T, Yabe T, Sudoh M, Satoh Y, Nakajima T, Arisawa M, et al. Role of three chitin synthase genes in the growth of Candida albicans. J Bacteriol 1996; 178: 2416-9.
26. Gaughran JP, Lai MH, Kirsch DR, Silverman SJ. Nikkomycin Z is a specific inhibitor of Saccharomyces cerevisiae chitin synthase isozyme Chs3 in vitro and in vivo. J Bacteriol 1994; 176: 5857-60.
27. Kim MK, Park HS, Kim CH, Park HM, Choi W. Inhibitory effect of nikkomycin Z on chitin synthases in Candida albicans. Yeast 2002; 19: 341-9.
28. Endo A, Kakiki K, Misato T. Mechanism of action of the antifungal agent polyoxin D. J Bacteriol 1970; 104: 189-96.
29. Bahmed K, Quilès F, Wathier M, Bonaly R, Benallaoua S, Pucci B, et al. Use of dansyl N-acetyl glucosamine as substrate for chitin synthetase activities. Proc Biochem 2005; 40: 2523-9.
30. Carrano L, Tavecchia P, Sponga F, Spreafico F. Dansyl N-acetyl glucosamine as a precursor of fluorescent chitin: a method to detect fungal cell wall inhibitors. J Antibiot 1996; 50: 177-9.
31. Ishiguro J, Saitou A, Durán A, Ribas JC. cpsl+, a Schizosaccharomyces pombe gene homolog of Saccharomyces cerevisiae FKS genes whose mutation confers hypersensitivity to cyclosporine A and papulacandin B. J Bacteriol 1997; 179: 7653-62.
32. Chio WJ, Cabib E. The use of divalent cations and pH for the determination of specific yeast chitin synthetases. Anal Biochem 1994; 219: 368-72.
33. Pitarch A, Nombela C, Gil C. Collection of proteins secreted from yeast protoplasts in active cell wall regeneration. Methods Mol Biol 2008; 425: 241-63.
34. Cassone A. Cell wall of Candida albicans: its functions and its impact on the host. Curr Top Med Mycol 1989;3: 248-314.
35. Chaffin WL, Pez-Ribot JL, Casanova M, Gozalbo D, Martinez JP. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev 1998; 62: 130-80.
36. Glotzer M. Cytokinesis: progress on all fronts. Curr Opin Cell Biol 2003; 15: 684-90.
37. Cabib E. The septation apparatus, a chitin-requiring machine in budding yeast. Arch Biochem Biophys 2004; 426: 201-7.
38. Schmidt M, Bowers B, Varma A, Roh DH, Cabib E. In budding yeast, contraction of the actomyosin ring and formation of the primary septum at cytokinesis depend on each other. J Cell Sci 2002; 115: 293-302.
39. Cabib E, Roh DH, Schmidt M, Crotti LB, Varma A. The yeast cell wall and septum as paradigms of cell growth and morphogenesis. J Biol Chem 2001; 276: 19 679-682.
40. Bulawa, CE. Genetics and molecular biology of chitin synthesis in fungi. Annu Rev Microbiol 1993; 47: 505-34.
41. Cid VJ, Duran A, del Rey F, Snyder MP, Nombela C, Sanchez M. Molecular basis of cell integrity and morphogenesis in Saccharomyces cerevisiae. Microbiol Rev 1995; 59: 345-86.
42. Shaw JA, Mol PC, Bowers B, Silverman SJ, Valdivieso MH, Durán A, et al. The function of chitin synthases 2 and 3 in the Saccharomyces cerevisiae cell cycle. J Cell Biol 1991; 114: 111-23.
43. Kollár R, Petráková E, Ashwell G, Robbins PW, Cabib E. Architecture of the yeast cell wall. The linkage between chitin and beta(1→3)-glucan. J Biol Chem 1995; 270: 1170-8.
44. Munro CA, Schofield DA, Gooday GW, Gow NA. Regulation of chitin synthesis during dimorphic growth of Candida albicans. Microbiology 1998; 144: 391-401.
45. Gow NA, Robbins PW, Lester JW, Brown AJ, Fonzi WA. A hyphalspecific chitin synthase gene (CHS2) is not essential for growth, dimorphism, or virulence of Candida albicans. Proc Natl Acad Sci USA 1994; 91: 6216-20.
46. Munro CA, Winter K, Buchan A, Henry K, Becker JM. Chs1 of Candida albicans is an essential chitin synthase required for synthesis of the septum and for cell integrity. Mol Microbiol 2001; 39: 1414-26.
47. Bowers B, Levin G, Cabib E. Effect of polyoxin D on chitin synthesis and septum formation in Saccharomyces cerevisiae. J Bacteriol 1974; 119: 564-75.
48. Cos T, Ford RA, Trilla JA, Duran A, Cabib E, Roncero C. Molecular analysis of Chs3p participation in chitin synthase III activity. Eur J Biochem 1998; 256: 419-26.
49. Choi WJ, Santos B, Duran A, Cabib E. Are yeast chitin synthases regulated at the transcriptional or the posttranslational level? Mol Cell Biol 1994; 14: 7685-94.
50. 3H] bleomycin A2 on Saccharomyces cerevisiae cell walls and membranes. Antimicrob Agents Chemother 1992; 36: 2497-505.
51. Hector RF. Compounds active against cell walls of medically important fungi. Clin Microbiol Rev 1993; 6: 1-21.